1. AstraZeneca plans 2020 filing for lupus drug — Shares of Amarin rise on positive FDA committee report on Vascepa — Amgen cutting 149 neuroscience R&D staff — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Regenesis Biomedical

Anonymous board for Regenesis Biomedical


Sort By:
Title
Replies Views
Last Message ↓
  1. Anonymous
    Replies:
    2
    Views:
    3,504
  2. Anonymous
    Replies:
    1
    Views:
    4,235
  3. Anonymous
    Replies:
    0
    Views:
    2,837
  4. Anonymous
    Replies:
    0
    Views:
    3,772

Thread Display Options

Loading...